Calvin Wesley Yee

USPTO Granted Patents = 15 (Patent Applications = 7)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 170(Granted Patents)

Location History:

South San Francisco, CA (US) (2017 - 2022)
Daly City, CA (US) (2011 - 2023)

Company Filing History:

13 out of 57

Global Blood Therapeutics, Inc.

Years Active: 2011-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12202817 - Cycloalkyl pyrimidines as ferroportin inhibitors (2025-01-21),

2. 11746100 - Cycloalkyl pyrimidines as ferroportin inhibitors (2023-09-05),

3. 11584734 - Tricyclic compounds as histone methyltransferase inhibitors (2023-02-21),

4. 11530191 - Compounds and uses thereof for the modulation of hemoglobin (2022-12-20),

5. 11286243 - Ferroportin inhibitors and methods of use (2022-03-29),

6. 11236109 - Compounds and uses thereof for the modulation of hemoglobin (2022-02-01),

7. 10829470 - Compounds and uses thereof for the modulation of hemoglobin (2020-11-10),

8. 10266551 - Compounds and uses thereof for the modulation of hemoglobin (2019-04-23),

9. 10144746 - Bridged bicyclic kallikrein inhibitors (2018-12-04),

10. 10100040 - Compounds and uses thereof for the modulation of hemoglobin (2018-10-16),

11. 9981939 - Compounds and uses thereof for the modulation of hemoglobin (2018-05-29),

12. 9815853 - Bridged bicyclic kallikrein inhibitors (2017-11-14),

13. 9695166 - Pyrazolopyridine pyrazolopyrimidine and related compounds (2017-07-04),

14. 7939531 - Pyrrolopyrazine kinase inhibitors (2011-05-10),

15. 7932254 - Pyrrolopyrazine kinase inhibitors (2011-04-26),

Title: Calvin Wesley Yee: Pioneering Inventor in BioPharma Innovations

Introduction:

Calvin Wesley Yee, a distinguished inventor based in Daly City, California, has made significant contributions to the field of bioPharma with his groundbreaking patents and innovative research efforts.

Latest Patents:

Yee's recent patents showcase his expertise in developing cutting-edge pharmaceutical compounds. His patents include Cycloalkyl pyrimidines as ferroportin inhibitors, targeting diseases related to iron metabolism disorders, and Tricyclic compounds as histone methyltransferase inhibitors, aimed at treating various cancers and hemoglobinopathies.

Career Highlights:

Yee has an impressive portfolio of 14 patents, reflecting his deep commitment to advancing medical science. He has worked with renowned companies such as Global Blood Therapeutics, Inc. and Roche Palo Alto LLC, where he has played a vital role in developing novel treatments for complex diseases.

Collaborations:

Throughout his career, Yee has collaborated closely with talented professionals in the field. Notable coworkers include Zhe Li and Qing Xu, who have worked alongside Yee on various projects, further enhancing the impact of his research and inventions.

Conclusion:

In conclusion, Calvin Wesley Yee stands out as a leading figure in the realm of bioPharma innovations. His relentless pursuit of excellence and dedication to improving patient outcomes through inventive solutions solidify his position as a trailblazing inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.